Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Who is it for: Medication eligibility and prescriptions are determined solely by licensed medical providers based on clinical appropriateness
Your healthcare provider may need to delay dose increases if you experience significant side effects, but should not accelerate the schedule beyond what's recommended in the FDA labeling
One panel member abstained from voting
In March 2024, the FDA further approved Wegovy to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight
US$ 24.56
US$ 23.47
US$ 27.63
